Skip to main content

Table 1 Specifications of Cardiometabolic Risk Factor Sets

From: Predicting waist circumference from body mass index

  Metabolic Syndrome NCEP-ATP IIIa Abdominal Obesity 1 (AO) AO + Diabetes AO + Dyslipidemia AO + Diabetes + Dyslipidemia Metabolic Syndrome IDFa Abdominal Obesity 2
  ≥3 of the following risk factors High WC High WC + diabetes High WC + high TG or low HDL High WC + diabetes + high TG or low HDL High WC + 2 of the other 4 risk factors High WC
WC Men ≥ 102 cm Men ≥ 102 cm Men ≥ 102 cm Men ≥ 102 cm Men ≥ 102 cm Men ≥ 94 cmb Men ≥ 94 cmb
  Women ≥ 88 cm Women ≥ 88 cm Women ≥ 88 cm Women ≥ 88 cm Women ≥ 88 cm Women ≥ 80 cmb Women ≥ 80 cmb
TG ≥ 150 mg/dL NA NA ≥ 150 mg/dL ≥ 150 mg/dL ≥ 150 mg/dL, or NA
       on treatment for high TG  
HDL Men < 40 mg/dL NA NA Men < 40 mg/dL Men < 40 mg/dL Men < 40 mg/dL NA
  Women < 50 mg/dL    Women < 50 mg/dL Women < 50 mg/dL Women < 50 mg/dL or  
       on treatment for low HDL  
BP SBP ≥ 130 mm Hg or NA NA NA NA SBP ≥ 130 mm Hg or NA
  DBP ≥ 85 mm Hg or      DBP ≥ 85 mm Hg or  
  current use of anti-hypertensive medication      current use of anti-hypertensive medication  
       (Same as for NCEP)  
FPG ≥ 100 mg/dL or NA ≥ 126 mg/dL or NA ≥ 126 mg/dL or ≥ 100 mg/dL or NA
  use of diabetes medication   use of diabetes medication   use of diabetes medication previously diagnosed type 2 diabetes NA
  1. WC waist circumference, TG triglycerides, HDL high-density lipoprotein, BP blood pressure, FPG fasting plasma glucose, NCEP National Cholesterol Education Program, ATP III Adult Treatment Panel III.
  2. a Ford, E. S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28:2745–2749.
  3. b For White and African American subjects. Refer to a Ford, E.S. article for other ethnic group-specific thresholds including for Mexican-American subjects.